ArticleBMC geriatrics2026
Patient and public involvement in pragmatic trials with older adults: a multi-methods study of researchers' experiences.
Article in BMC geriatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Questions for more insightful and useful analyses of barriers and facilitators to public involvement and engagement in health research: a critical narrative review.Research involvement and engagement · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPatient and Public Involvement (PPI) in health research, including clinical trials, enhances research relevance and quality. However, data on PPI prevalence and characteristics in trials involving older adults remain scarce. We aimed to describe the prevalence and nature of PPI in trials with older adults and identify the main benefits and challenges associated with PPI in such trials.
methodsWe conducted a multi-methods study, embedded within a survey of 3,163 corresponding authors of pragmatic trials published between 2014 and 2019. We used authors' self-reports and an electronic search filter to identify the subset involving the older adult population (≥65 years). We approached interested respondents who indicated that they had conducted PPI to participate in a semi-structured interview. Survey results were summarized using descriptive statistics, and interview transcripts were analyzed using thematic analysis.
resultsOne hundred authors met the eligibility criteria, having completed the survey and been involved in a trial involving older adults. Most respondents were women (64.8%). PPI was reported in 46.0% of trials, primarily involving in-person discussions. Most respondents (90.7%) perceived PPI as beneficial, citing improved interventions, increased applicability of findings, higher research quality, and enhanced recruitment/retention. Challenges included communicating trial design, methods, and results (62.5%), identifying or recruiting PPI partners (50%), scheduling meetings (45.8%), and sustaining involvement (45.8%). Thematic analysis of N=8 interviews revealed five main themes related to challenges, some specific to older adults: recruitment and retention of PPI partners, importance of a good PPI chair, training for PPI partners, workload for researchers and burden for PPI partners, and procedural barriers. PPI partners influenced various research aspects, sometimes described as exceeding expectations, by influencing aims and outcomes to measure, developing interventions, refining patient-facing materials, aiding recruitment and retention, and contributing to analysis and interpretation of results.
conclusionDespite being implemented in fewer than half of the trials, PPI had a significant perceived impact. Addressing identified challenges, both general and specific to older adults, could enhance PPI uptake, as well as the quality and relevance of research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.